MIRA INFORM REPORT

 

 

Report No. :

346892

Report Date :

27.10.2015

 

IDENTIFICATION DETAILS

 

Name :

JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.

 

 

Registered Office :

Yunyang Industry Park, Danyang, Jiangsu Province 212300 Pr

 

 

Country :

China

 

 

Financials (as on) :

30.06.2015

 

 

Date of Incorporation :

22.10.1998

 

 

Com. Reg. No.:

321100000069242

 

 

Legal Form :

Shares Limited Company

 

 

Line of Business :

Subject is engaged in manufacturing and selling medical equipment.

 

 

No. of Employees :

2,330

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

China

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

CHINA - ECONOMIC OVERVIEW

 

Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, growth of the private sector, development of stock markets and a modern banking system, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors considered important to "economic security," explicitly looking to foster globally competitive industries. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2014 stood as the largest economy in the world, surpassing the US for the first time in modern history. Still, China's per capita income is below the world average.

After keeping its currency tightly linked to the US dollar for years, in July 2005 China moved to an exchange rate system that references a basket of currencies. From mid-2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation. In 2014 the People’s Bank of China (PBOC) doubled the daily trading band within which the RMB is permitted to fluctuate.

The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic consumption; (b) facilitating higher-wage job opportunities for the aspiring middle class, including rural migrants and increasing numbers of college graduates; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2014 more than 274 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development.

Several factors are converging to slow China's growth, including debt overhang from its credit-fueled stimulus program, industrial overcapacity, inefficient allocation of capital by state-owned banks, and the slow recovery of China's trading partners. The government's 12th Five-Year Plan, adopted in March 2011 and reiterated at the Communist Party's "Third Plenum" meeting in November 2013, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent in the future on fixed investments, exports, and heavy industry. However, China has made only marginal progress toward these rebalancing goals. The new government of President XI Jinping has signaled a greater willingness to undertake reforms that focus on China's long-term economic health, including giving the market a more decisive role in allocating resources. In 2014 China agreed to begin limiting carbon dioxide emissions by 2030. China also implemented several economic reforms in 2014, including passing legislation to allow local governments to issue bonds, opening several state-owned enterprises to further private investment, loosening the one-child policy, passing harsher pollution fines, and cutting administrative red tape.

 

Source : CIA

 


Company name & address

 

JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.

YUNYANG INDUSTRY PARK, DANYANG, JIANGSU PROVINCE 212300 PR CHINA

TEL: 86 (0) 511-86900802

FAX: 86 (0) 511-86900876

 

 

EXECUTIVE SUMMARY

 

Date of Registration         : october 22, 1998

REGISTRATION NO.                  : 321100000069242

LEGAL FORM                           : SHARES LIMITED COMPANY

CHIEF EXECUTIVE                     : WU GUANGMING (LEGAL REPRESENTATIVE)

REGISTERED CAPITAL : CNY 584,767,040

staff                                      : 2,330

BUSINESS CATEGORY : manufacturing & trading

REVENUE                                : CNY 1,091,739,000 (FROM JAN. 1, 2015 TO JUN. 30, 2015)

EQUITIES                                 : CNY 2,016,882,000 (AS OF JUN. 30, 2015)

WEBSITE                                  : www.yuyue.com.cn

E-MAIL                                     : webmaster@yuyue.com.cn

PAYMENT                                : AVERAGE

MARKET CONDITION                : COMPETITIVE

FINANCIAL CONDITION             : fairly good

OPERATIONAL TREND : fairly Steady

GENERAL REPUTATION           : average

EXCHANGE RATE                    : CNY 6.35 = USD 1

 

 

Adopted abbreviations (as follows)

 

SC – Subject Company (the company inquired by you)

N/A – Not available

CNY – China Yuan Ren Min Bi

 

 

OPERATIONAL TREND & GENERAL REPUTATION

 

This section aims at indicating the relative positions of SC in respect of its operational trend & general reputation

 

Operational Trend:-                                            General Reputation:-

Upward                                                             Excellent

Steady                                                              Good

Fairly Steady                                                     Fairly Good

Ordinary                                                            Average

Fair                                                                   Fair

Stagnant                                                           Detrimental

Downward                                                         Not known

Not known                                                         Not yet be determined

Not yet be determined

 

 

LEGAL STATUS & HISTORY

 

SC was established as a shares limited company of PRC with State Administration of Industry & Commerce (SAIC) under registration No.: 321100000069242 on October 22, 1998.

 

SC’s Organization Code Certificate No.: 70395265-7

 

SC’s registered capital: CNY 584,767,040

 

SC’s paid-in capital: CNY 584,767,040

 

Registration Change Record:-

 

Date

Change of Contents

Before the change

After the change

2015-6-18

Registered Capital

CNY 531,606,400

CNY 584,767,040

 

Current Co search indicates SC’s shareholders & chief executives are as follows:-

 

Name of Shareholder (s) (As of Jun. 30, 2015)

% of Shareholding

Jiangsu Yuyue Technology Development Co., Ltd.

29.85

Wu Guangming

11.79

Wu Qun

8.82

Shenzhen Qianhai Hongshan Guangming Investment Management Center (Limited Partnership)

7

Bank of China Co., Ltd.-Gongyin Ruixin Medical Health Industry Stock Securities Investment Fund

2.01

New China Life Insurance Company Ltd.-Bonus-Personal Bonus-018L-FH002 Shen

0.66

National Social Security Fund No. 114

0.64

Norway Central Bank-Own Assets

0.58

New China Life Insurance Company Ltd.-Bonus-Group Bonus-018L-FH001 Shen

0.56

Industrial Bank of China Co., Ltd.- Sino-Euro New Trend Equity Securities Investment Fund

0.55

Other Shareholders

37.54

 

SC’s Chief Executives:-

 

Position

Name

Legal Representative, Chairman and General Manager

Wu Guangming

Vice Chairman

Wu Qun

Director

Jing Guomin

Chen Ping

Zheng Hongzhe

Chen Jian

PENGHUI CHEN

Zhong Mingxia

Chen Yi

Supervisor

Yin Guozhen

Xu Kunfeng

Chen Jianjun

Cao Yang

Feng Yonghong

Cai Linquan

Yu Xiongfeng

 

 

RECENT DEVELOPMENT

 

SC is a listed company in Shenzhen Stock Exchange Market with the code of 002223.

 

 

SHAREHOLDER CHART & BACKGROUND

 

Name                                                                                                                             % of Shareholding

(As of Jun. 30, 2015)

----------------------------------

Jiangsu Yuyue Technology Development Co., Ltd.                                                                                 29.85

 

Wu Guangming                                                                                                                                     11.79

 

Wu Qun                                                                                                                                                8.82

 

Shenzhen Qianhai Hongshan Guangming Investment Management Center (Limited Partnership)                 7

 

Bank of China Co., Ltd.-Gongyin Ruixin Medical Health Industry Stock Securities Investment Fund            2.01

 

 

New China Life Insurance Company Ltd.-Bonus-Personal Bonus-018L-FH002 Shen                                   0.66

 

National Social Security Fund No. 114                                                                                                    0.64

 

Norway Central Bank-Own Assets                                                                                                           0.58

 

New China Life Insurance Company Ltd.-Bonus-Group Bonus-018L-FH001 Shen                                       0.56

 

Industrial Bank of China Co., Ltd.- Sino-Euro New Trend Equity Securities Investment Fund                      0.55

 

Other Shareholders                                                                                                                                37.54

 

Jiangsu Yuyue Technology Development Co., Ltd.

-------------------------------------------------------------

Registration No.: 321181000062146

Legal Form: Limited Liabilities Company

Registered Capital: CNY 125,000,000

Legal Representative: Wu Guangming

 

 

MANAGEMENT

 

Wu Guangming, Legal Representative, Chairman and General Manager

---------------------------------------------------------------------------------------------------------

Ø  Gender: M

Ø  Age: 53

Ø  Qualification: EMBA

Ø  Working experience (s):

 

At present, working in SC as legal representative, chairman and general manager

Also working in Jiangsu Yuyue Technology Development Co., Ltd. as legal representative

 

Wu Qun, Vice Chairman

-----------------------------------------

Ø  Gender: M

Ø  Age: 27

Ø  Qualification: Master Degree

Ø  Working experience (s):

 

At present, working in SC as vice chairman

 

Director

-----------

Jing Guomin

Chen Ping

Zheng Hongzhe

Chen Jian

PENGHUI CHEN

Zhong Mingxia

Chen Yi

 

Supervisor

--------------

Yin Guozhen

Xu Kunfeng

Chen Jianjun

Cao Yang

Feng Yonghong

Cai Linquan

Yu Xiongfeng

 

 

BUSINESS OPERATION

 

SCs registered business scope includes manufacturing and selling medical equipment and health care products; selling metal materials; exporting its products; and importing machinery, components, raw materials and accessories.

 

SC is mainly engaged in manufacturing and selling medical equipment.

 

SC’s products mainly include:

Respiratory

Circulatory System

Endocrine System

Homecare

Hospital Equipment

 

SC sources its materials 80% from domestic market, and 20% from overseas market. SC sells 40% of its products in domestic market, and 60% to overseas market.

 

The buying terms of SC include Check, T/T, L/C and Credit of 30-60 days. The payment terms of SC include T/T, L/C and Credit of 30-60 days.

 

*Major Customers*

-----------------------

Invacare Corporation

Cramer Decker Industries

Spiracle Technology

 

Staff & Office:

--------------------------

SC is known to have approx. 2,330 staff at present.

 

SC owns an area as its operating office and factory, but the detailed information is unknown.

 

 

RELATED COMPANY

 

SC is known to invest in the following companies:

 

Jiangsu Yuyue Medical Instruments Co., Ltd.

 

Jiangsu Yuyue Information System Co., Ltd.

 

Nanjing Yuyue Software Technology Co., Ltd.

 

Suzhou Medical Appliance Factory

 

Shanghai Yuyue Medical Equipment Co., Ltd.

 

Suzhou Yuyue Medical Technology Co., Ltd.

 

PAYMENT

 

Overall payment appraisal:

( ) Excellent      ( ) Good      (X) Average      ( ) Fair      ( ) Poor      ( ) Not yet be determined

The appraisal serves as a reference to reveal SC's payments habits and ability to pay.  It is based on the 3 weighed factors: Trade payment experience (through current enquiry with SC's suppliers), our delinquent payment and our debt collection record concerning SC.

 

Trade payment experience: SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record: None in our database.

 

Debt collection record: No overdue amount owed by SC was placed to us for collection within the last 6 years.

 

 

BANKING

 

The bank information of SC is not filed in SAIC.

 

 

FINANCIALS

 

Consolidated Balance Sheet

 

Unit: CNY’000

As of Dec. 31, 2014

As of Jun. 30, 2015

Cash

363,521

872,556

Accounts receivable

431,859

792,520

Notes receivable

306,608

212,018

Advances to suppliers

117,045

56,049

Interest receivable

0

0

Other receivable

65,054

64,808

Inventory

302,096

208,130

Non-current assets within one year

0

0

Other current assets

4,238

830

 

------------------

------------------

Current assets

1,590,421

2,206,911

Financial assets available for sale

281

52,281

Long-term investments

6,690

6,092

Real estate investment

0

0

Fixed assets

404,565

391,565

Construction in progress

24,420

25,835

Project materials

0

0

Intangible assets

68,963

277,052

Goodwill

19,385

21,625

Long-term deferred expense

12,351

12,491

Deferred income tax assets

11,228

13,814

Other non-current assets

0

0

 

------------------

------------------

Total assets

2,138,304

3,007,666

 

=============

=============

Short-term loans

50,000

150,000

Notes payable

0

0

Accounts payable

244,890

292,164

Payroll payable

4,554

8,118

Taxes payable

2,979

59,162

Advances from clients

23,851

16,056

Dividends payable

17,604

12,957

Other payable

0

0

Other current liabilities

913

457

 

------------------

------------------

Current liabilities

344,791

538,914

Non-current liabilities

31,878

451,870

 

------------------

------------------

Total liabilities

376,669

990,784

Equities

1,761,635

2,016,882

 

------------------

------------------

Total liabilities & equities

2,138,304

3,007,666

 

=============

=============

 

Consolidated Income Statement

 

Unit: CNY’000

As of Dec. 31, 2014

From Jan. 1, 2015 to Jun. 30, 2015

Revenue

1,681,802

1,091,739

Cost of sales

1,009,411

640,168

Taxes and surcharges

13,041

12,344

    Sales expense

148,438

58,831

    Management expense

215,942

102,130

    Finance expense

-2,858

-2,234

    Asset impairment loss

13,448

21,424

Investment income

485

-598

Non-operating income

50,110

35,548

    Non-operating expense

1,282

674

Profit before tax

333,693

293,351

Less: profit tax

35,803

40,852

Profits

297,890

252,499

 

Important Ratios

=============

 

As of Dec. 31, 2014

As of Jun. 30, 2015

*Current ratio

4.61

4.10

*Quick ratio

3.74

3.71

*Liabilities to assets

0.18

0.33

*Net profit margin (%)

17.71

23.13

*Return on total assets (%)

13.93

8.40

*Inventory / Revenue ×365/180

66 days

35 days

*Accounts receivable / Revenue ×365/180

94 days

131 days

*Revenue / Total assets

0.79

0.36

*Cost of sales / Revenue

0.60

0.59

 

FINANCIAL COMMENTS

 

PROFITABILITY: FAIRLY GOOD

l  The revenue of SC appears fairly good in its line.

l  SC’s net profit margin is fairly good.

l  SC’s return on total assets is fairly good.

l  SC’s cost of goods sold is average, comparing with its revenue.

 

LIQUIDITY: FAIRLY GOOD

l  The current ratio of SC is maintained in a fairly good level.

l  SC’s quick ratio is maintained in a fairly good level.

l  The inventory of SC appears average.

l  The accounts receivable of SC appears average.

l  SC’s short-term loans are in an average level

l  SC’s revenue is in a fair level, comparing with the size of its total assets.

 

LEVERAGE: FAIRLY GOOD

l  The debt ratio of SC is average.

l  The risk for SC to go bankrupt is low.

 

Overall financial condition of the SC: Fairly Good.

 

 

CONCLUSIONS

 

SC is considered large-sized in its line with fairly good financial conditions.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.64.96

UK Pound

1

Rs.99.54

Euro

1

Rs.71.64

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAS

 

 

Report Prepared by :

DPT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.